Vaxcyte Inc. (PCVX)
NASDAQ: PCVX
· Real-Time Price · USD
32.66
1.23 (3.91%)
At close: Aug 15, 2025, 3:59 PM
32.70
0.12%
After-hours: Aug 15, 2025, 04:54 PM EDT
Vaxcyte Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 14.45M | 14.45M | 14.45M | 14.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 9.49M | 7.98M | 11.07M | 14.02M | 12M | 10.92M | 10.17M | 9.52M | 9.4M | 9.16M | 9.19M | 8.09M | 6.58M | 5.29M | 3.45M | 2.24M | 1.4M | 527K |
Gross Profit | -9.49M | -7.98M | -11.07M | 426K | 2.45M | 3.53M | 4.28M | -9.52M | -9.4M | -9.16M | -9.19M | -8.09M | -6.58M | -5.29M | -3.45M | -2.24M | -1.4M | -527K |
Operating Income | -709.11M | -635.87M | -569.55M | -529.05M | -502.15M | -436.32M | -393.04M | -357.94M | -303.49M | -264.23M | -232.26M | -175.53M | -143.9M | -119.75M | -103.67M | -93.28M | -87.63M | -85.13M |
Interest Income | 128.52M | 121.26M | 109.99M | 91.1M | 81.54M | 74.18M | 62.91M | 51.97M | 34.67M | 18.61M | 8.36M | 1.82M | 722K | 416K | 343K | 276K | 219K | 170K |
Pretax Income | -547.5M | -509.63M | -463.93M | -507.65M | -497.19M | -436.82M | -402.27M | -299.51M | -264.77M | -244.96M | -223.49M | -174M | -142.7M | -117.84M | -100.08M | -92.25M | -86.65M | -83.3M |
Net Income | -547.5M | -509.63M | -463.93M | -507.65M | -497.19M | -436.82M | -390.17M | -302.81M | -267.4M | -248.24M | -238.63M | -173.75M | -143.11M | -117.61M | -100.08M | -92.25M | -86.65M | -83.3M |
Selling & General & Admin | 111.25M | 102.2M | 89.42M | 75.45M | 68.06M | 64.52M | 57.75M | 55.13M | 50.42M | 45.38M | 39.81M | 34.63M | 30.25M | 26.92M | 25.26M | 23.28M | 21.65M | 18.62M |
Research & Development | 592.86M | 530.19M | 476.64M | 447.18M | 427.67M | 368.85M | 332.34M | 279.82M | 230.08M | 195.85M | 169.45M | 140.9M | 113.65M | 92.83M | 78.41M | 70M | 65.98M | 66.51M |
Other Expenses | n/a | -394K | -394K | -394K | -394K | n/a | -654K | -1.58M | -1.74M | -2.43M | -1.93M | -1.92M | -2.06M | -1.75M | -1.58M | -677K | -378K | n/a |
Operating Expenses | 704.12M | 632.39M | 565.94M | 522.5M | 495.6M | 430.78M | 386.98M | 330.9M | 276.29M | 238.81M | 207.33M | 173.62M | 141.85M | 118M | 102.08M | 92.27M | 86.14M | 82.98M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 2K | 2K | 2K | 7K | 7K | 7K | 7K | n/a |
Selling & Marketing Expenses | n/a | -3.48M | -3.48M | -6.43M | -6.43M | -2.95M | -2.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 709.11M | 635.87M | 569.42M | 528.93M | 502.03M | 433.73M | 389.92M | 330.9M | 276.29M | 238.81M | 207.33M | 173.62M | 141.85M | 118M | 102.08M | 92.27M | 86.14M | 82.98M |
Income Tax Expense | n/a | n/a | n/a | 14.58M | 14.58M | 14.58M | 2.48M | 3.3M | 2.64M | 3.28M | 15.15M | -249K | 421K | -218K | 17K | 17K | 7K | n/a |
Shares Outstanding (Basic) | 136.03M | 135.69M | 122.85M | 123.69M | 117.26M | 111.69M | 102.53M | 101.67M | 98.06M | 86.21M | 79.01M | 61.99M | 60.82M | 57.33M | 52.81M | 52.19M | 51.48M | 51.17M |
Shares Outstanding (Diluted) | 136.03M | 135.69M | 122.85M | 123.69M | 117.26M | 111.69M | 102.53M | 101.67M | 98.06M | 86.21M | 79.01M | 61.99M | 60.82M | 57.55M | 52.81M | 52.19M | 51.51M | 51.17M |
EPS (Basic) | -4.21 | -4.09 | -3.9 | -4.54 | -4.62 | -4.22 | -3.93 | -3.35 | -3.36 | -3.47 | -3.59 | -2.95 | -2.54 | -2.19 | -1.92 | -1.79 | -2.3 | -3.56 |
EPS (Diluted) | -4.21 | -4.09 | -3.9 | -4.54 | -4.62 | -4.22 | -3.93 | -3.35 | -3.36 | -3.47 | -3.58 | -2.94 | -2.53 | -2.18 | -1.92 | -1.79 | -2.3 | -3.56 |
EBITDA | -530M | -521.4M | -458.95M | -584.23M | -534.49M | -468.66M | -425.66M | -323.52M | -288.9M | -249.63M | -215.77M | -167.42M | -137.63M | -112.55M | -98.55M | -91.6M | -86.55M | -83.66M |
EBIT | -544.36M | -530.37M | -463.93M | -587.37M | -540.4M | -472.49M | -428.69M | -325.94M | -291.19M | -255.03M | -223.56M | -174.07M | -142.77M | -117.92M | -102M | -94.17M | -88.58M | -85.22M |
Depreciation & Amortization | 14.65M | 13.14M | 11.35M | 9.52M | 12M | 10.92M | 10.17M | 9.52M | 9.4M | 9.16M | 9.19M | 8.09M | 6.58M | 5.29M | 3.45M | 2.57M | 2.06M | 1.55M |